New York State Common Retirement Fund Janux Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 15,964 shares of JANX stock, worth $580,610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,964
Previous 8,646
84.64%
Holding current value
$580,610
Previous $393,000
117.56%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding JANX
# of Institutions
228Shares Held
55.2MCall Options Held
687KPut Options Held
357K-
Ra Capital Management, L.P. Boston, MA10.4MShares$377 Million8.99% of portfolio
-
Janus Henderson Group PLC London, X03.56MShares$130 Million0.1% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.52MShares$128 Million7.18% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.06MShares$111 Million0.3% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$85.3 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.52B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...